Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-09
- Target Recruit Count
- 12
- Registration Number
- NCT06963346
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Phase I/II Clinical Trial f CD40L-augmented TIL for Patients With Advanced Melanoma
Phase 1
Not yet recruiting
- Conditions
- Melanoma
- Interventions
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-07
- Target Recruit Count
- 36
- Registration Number
- NCT06961357
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
- First Posted Date
- 2025-04-27
- Last Posted Date
- 2025-05-14
- Target Recruit Count
- 39
- Registration Number
- NCT06947083
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
NutritiOUs fRuIts and veggieS to Improve Health: A Culinary Medicine Intervention
Not Applicable
Recruiting
- Conditions
- Cancer, Nos
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Target Recruit Count
- 24
- Registration Number
- NCT06926972
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Aim 1: App for Reducing Cravings to Smoke
Not Applicable
Completed
- Conditions
- Smoking
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Target Recruit Count
- 10
- Registration Number
- NCT06923033
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients
Not Applicable
Recruiting
- Conditions
- Smoking Cessation
- First Posted Date
- 2025-04-03
- Last Posted Date
- 2025-04-22
- Target Recruit Count
- 90
- Registration Number
- NCT06909357
- Locations
- 🇺🇸
University of Miami, Coral Gables, Florida, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
Phase 2
Recruiting
- Conditions
- Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 75
- Registration Number
- NCT06860386
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
Phase 2
Recruiting
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-04
- Target Recruit Count
- 21
- Registration Number
- NCT06855212
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
Phase 2
Recruiting
- Conditions
- Breast CancerNode-positive Breast Cancer
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-03-14
- Target Recruit Count
- 120
- Registration Number
- NCT06833502
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Exploring Men s Prostate Cancer Genetic Risk Perceptions
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-04-10
- Target Recruit Count
- 100
- Registration Number
- NCT06764992
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath